Recruiting nowPhase 2, Phase 3
Effect of Weight Loss on Physical and Cardiac Performance in People With Obesity and Heart Failure
Updated 2026-06-23 · NCT06423599See eligibility →
Treatment
Semaglutide Injectable Product clinical trials
Active studies that list Semaglutide Injectable Product as an intervention or treatment.
5active studies
4recruiting now
3countries represented
2largest site network
Current studies
Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.
Recruiting nowNot applicable
Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV
Updated 2026-04-29 · NCT04174755See eligibility →
Updated 2026-04-13 · NCT06706284See eligibility →
Updated 2026-02-06 · NCT07136714See eligibility →
Active, not recruitingPhase 2
Effects of Semaglutide in HIV-Associated Lipohypertrophy
Updated 2026-05-04 · NCT04019197See eligibility →
Related treatments
How current is this page?
The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.
Does appearing here mean I qualify?
No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.